CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The chemokine CXCL9 inhibits neoangiogenesis and liver fibrosis in vivo
DOI 10.1055/s-0030-1269495
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Sahin, M Moreno Zaldivar, P Schmitz, F Kießling, C Trautwein, HE Wasmuth
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2011
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Recently we identified CXCR3 and its ligand CXCL9 as an antifibrotic pathway in the liver (Wasmuth et al. Gastroenterology 2009). Notably, ligands of CXCR3 also have angiostatic actions, rendering them as potential therapeutic options in liver fibrosis. The aims of the current projects were to characterise neoangiogenesis in CXCR3-/- and wild-type mice after CCl4 treatment and to investigate the possibility of…
Zitieren
Zitierempfehlung
H Sahin, M Moreno Zaldivar, P Schmitz, F Kießling, C Trautwein, HE Wasmuth (2011) The chemokine CXCL9 inhibits neoangiogenesis and liver fibrosis in vivo. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0030-1269495
Mit CareLit weiterarbeiten